Podostroma cornu-damae Compounds for Cancer Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current anticancer drugs often come with severe side effects such as nausea, bone marrow suppression, and kidney toxicity, necessitating the development of novel agents with higher safety and efficacy.

Innovation Solution

Development of compounds isolated from Podostroma cornu-damae or its culture, specifically structural formulae 1 to 3, which inhibit cancer cell proliferation, administered through pharmaceutical or food compositions, using extraction and purification methods involving solvents and chromatography.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional anticancer drugs (cisplatin, adriamycin, mitomycin-C) are used, then cancer treatment efficacy is improved, but severe side effects occur including kidney toxicity, bone marrow suppression, and hematopoietic toxicity

Engineering Contradiction:
Improvecancer treatment efficacyVSAvoidside effects and toxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and utilizes natural compounds from the fungus Podostroma cornu-damae as anticancer agents. Specifically, compounds including trichothecene derivatives and other metabolites are isolated from the fungal culture, providing an alternative source of anticancer activity that differs from synthetic chemotherapy agents, thereby potentially reducing the severe side effects associated with conventional drugs while maintaining treatment efficacy

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs parameter changes by modifying the chemical structure of natural fungal compounds to optimize their anticancer activity and reduce toxicity. Through structural modification and selection of specific compounds with defined molecular structures (as shown in the patent's structural formulas), the therapeutic window is improved, achieving better efficacy-toxicity ratio compared to conventional anticancer drugs

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If chemically synthesized anticancer substances are used, then cancer treatment options are available, but safety concerns arise due to severe adverse reactions

Engineering Contradiction:
Improvecancer treatment optionsVSAvoidsafety
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent converts the potential harm of toxic compounds into benefit by carefully selecting and optimizing specific natural compounds from Podostroma cornu-damae. The fungus naturally produces compounds with varying toxicity levels; through isolation, structural identification, and selection of compounds with favorable safety profiles (such as those with specific molecular structures shown in the patent), the harmful aspects are converted into therapeutic benefits with reduced side effects

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent uses natural fungal metabolites as intermediary substances that mediate between the need for effective cancer treatment and the requirement for safety. These naturally derived compounds serve as intermediaries that provide anticancer activity through different mechanisms than synthetic drugs, potentially avoiding the severe adverse reactions associated with conventional chemotherapy while still achieving tumor cell inhibition

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS11168092B2Compounds and method of preventing or treating cancer using the same
Publication Date: 2021.11.09 RES & BUSINESS FOUND SUNGKYUNKWAN UNIV
  • US11168092B2 patent drawing
  • US11168092B2 patent drawing
  • US11168092B2 patent drawing

AI summary

The present disclosure relates to novel compounds and a method of preventing or treating cancer using the same, and more particularly to compounds having structural formulae 1 to 3. The compounds of the present disclosure exhibit an excellent activity of inhibiting various cancer cells, and thus can be effectively used in a composition or method for preventing, alleviating, or treating cancer.